Spanopoulos, D. ., Barrett, B. ., Busse, M. ., Roman, T. ., & Poole, C. . (2018). Prescription of DPP-4 Inhibitors to Patients With Adult Type 2 Diabetes Mellitus and Creatinine Clearance>50 mL/min: The UK Primary Care Experience. Clin Ther. http://doi.org/10.1016/j.clinthera.2018.06.002
D. Spanopoulos
First name
D.
Last name
Spanopoulos
Spanopoulos, D. ., Barrett, B. ., Busse, M. ., Roman, T. ., & Poole, C. . (2018). Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience. Clin Ther. http://doi.org/10.1016/j.clinthera.2017.11.009
Spanopoulos, D. ., Okhai, H. ., Zaccardi, F. ., Tebboth, A. ., Barrett, B. ., Busse, M. ., … Khunti, K. . (2019). Temporal variation of renal function in people with type 2 diabetes mellitus: a retrospective UK Clinical Practice Research Datalink cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13734
Spanopoulos, D. ., Busse, M. ., Webb, J. ., Tebboth, A. ., Gollop, N. D., & Marcus, M. W. (2019). DPP-4 Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary Experience From UK General Practice. Clin Ther. http://doi.org/10.1016/j.clinthera.2019.05.010
Webb, J. ., Mount, J. ., von Arx, L. B., Rachman, J. ., Spanopoulos, D. ., Wood, R. ., … Idris, I. . (2021). Cardiovascular risk profiles: A cross-sectional study evaluating the generalisability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials Rewind, Leader and Sustain-6 to the real-world type 2 diabetes population in the UK. Diabetes Obes Metab. http://doi.org/10.1111/dom.14580